Pharmacy Resident - PGY2 Infectious Disease

• 
  JOB DUTIES
  

This PGY2 Infectious Diseases Pharmacy Residency Program is designed to prepare competent practitioners in the areas of infectious diseases and antimicrobial stewardship. Its graduates will be prepared to seek clinical specialist positions in these areas or tenure-track positions within academic medical centers and university-affiliated schools of pharmacy. Furthermore, upon completion of this program, graduates will be positioned to sit for the advanced practice Board Certification exam in Infectious Diseases (BCIDP). UCLA Health is an academic medical center (two campuses) with the capability of providing its PGY2 Infectious Diseases Pharmacy Resident with a well-rounded experience in direct patient care activities, longitudinal and collaborative research opportunities, teaching and lecture responsibilities, building leadership and organizational skills, and mentoring opportunities across many disciplines. The PGY2 ID Pharmacy Resident will gain or reinforce their clinical knowledge in the areas of infectious diseases pharmacotherapy, clinical microbiology and disease state management for both adult and pediatric patients with infectious diseases complications. Our PGY2 ID Pharmacy Resident will be expected to serve as the infectious diseases clinical content expert to multiple disciplines throughout the academic year: adult and pediatric infectious diseases, neurocritical care, emergency room medicine, orthopedics and solid organ transplant (including bone marrow transplant) infectious diseases. As a member of the health care team, the PGY2 Infectious Diseases Pharmacy Resident must function independently through assessment, research and application of knowledge to optimize therapeutic drug therapy for his/her patients. This PGY2 ID Pharmacy Resident will serve in the layered learning model as a co-preceptor to affiliated school of pharmacy Advanced Pharmacy Practice Experience (APPE) pharmacy students and UCLA PGY1 pharmacy residents. The PGY2 ID Pharmacy Resident will have the opportunity to participate in the ambulatory care clinics and transitions of care setting as longitudinal care experiences throughout the year: Infectious Diseases Transitions of Care (IDTS)/Outpatient Parenteral Antimicrobial Therapy (OPAT) and Adult HIV Care. The PGY2 ID Pharmacy Resident will have research opportunities that may include pharmacokinetic/pharmacodynamic therapeutic drug modeling studies or anti-infective utilization and/or outcome-based studies with the expectation that the results will be presented at a major pharmacy or infectious diseases conference. Leadership development opportunities will present themselves throughout the year with the PGY2 ID Pharmacy Resident taking an active role in medication safety efforts, participation within the University of California, Infectious Diseases Collaborative monthly meetings and related Infectious Diseases Resident Network (IDRN), co-chairing the Antibiotic Subcommittee meetings as well as participating in other designated standing Health-System-wide committees and initiatives. 1 year contract Annual Salary: $62,500

• 
  JOB QUALIFICATIONS
  

·         Graduation from an ACPE-accredited school of pharmacy with a Doctor of Pharmacy (Pharm.D.) degree or possess a Foreign Pharmacy Graduate Equivalency Committee (FPGEC) certificate from the National Association of Boards of Pharmacy (NABP). ·         Pharmacist licensure or Intern Pharmacist licensure (for out-of-state applicants) in the State of California PRIOR to the beginning of the residency program PGY1 and PGY2 pharmacy residents are required to obtain pharmacist licensure from the California State Board of Pharmacy by the end of the first 90 days of the respective residency program start date. ·         Complete a personal, on-site or remote interview with the Residency Selection Committee. This detailed interview process is outlined in the Pharmacy Residency Manual. * Completion of ASHP accredited PGY1 residency ·         ACLS certification from the American Heart Association ideally within the first month of residency program start but no later than September of the residency year. ·         Successful completion of the pre-employment process, including but not limited to verification of all required licenses and certifications, meeting the U.S. Office of Inspector General requirements and proof of a legal right to work in the United States. ·         Successful completion of a post-offer physical exam, which includes a drug and alcohol screen, a physical and a TB test. ·         For the safety and well-being of the university community, the University of California requires employees to be fully vaccinated against COVID-19 before physically accessing the University’s Locations and Programs. This requirement is subjected to limited deferrals, exceptions or accommodations based on medical condition, disability, or religious belief, and associated non-pharmaceutical interventions. For more information, visit UCLA COVID-19 Vaccination Policy Announcement at [1] https://covid-19.ucla.edu/uc-announces-covid-19-vaccination-policy/ and Full UC COVID-19 Vaccination Program Policy at [2] https://policy.ucop.edu/doc/5000695/SARS-CoV-2_Covid-19 ·         Knowledge of laws, regulations, and standards relative to pharmacy practice. ·         Ability to actively participate in a teaching and training program. ·         Excellent written and verbal communication skills. ·         Demonstrated skill in establishing and maintaining data files. ·         Demonstrated skill and ability in communicating on a one-to-one basis in order to obtain information, explain protocols and/or policies and procedures. ·         Demonstrated ability to speak in front of large groups to present didactic course material or scientific data. ·         Demonstrated ability to understand and interpret current scientific literature. ·         Demonstrated knowledge and ability to perform pharmacokinetic calculations. ·         Demonstrated ability to identify, retrieve and compile selected information from patients’ medical records for the purposes of evaluating appropriateness, effectiveness, predicted outcome and risks for toxicity. ·         Demonstrated skill and ability to provide, communicate and document drug information on pharmacological agents concisely to health professionals, patients and other lay individuals. References Visible links 1. https://covid-19.ucla.edu/uc-announces-covid-19-vaccination-policy/ 2. https://policy.ucop.edu/doc/5000695/SARS-CoV-2_Covid-19